![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
X
20
Hebei Veyong Pharmaceutical Co., Ltd. Shijiazhuang Cn, based in China, is a pharmaceutical company.
One of their significant offerings is Ivermectin, Process II, supported by a 'Valid' Certificate of Suitability (CEP) with the number R0-CEP 2021-477 - Rev 00
This Chemical Type CEP, issued on April 22, 2022, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.
Substance Number 1336 associated with this CEP further emphasizes